Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab ( DrugBank: Bortezomib, Cyclophosphamide, Dexamethasone, Daratumumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
28	全身性アミロイドーシス	1

28. 全身性アミロイドーシス

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-183929	17/7/2018	13/04/2018	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	Amyloidosis	Intervention name : Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab INN of the intervent ...	Janssen Pharmaceutical K.K.	NULL	complete	20		BOTH	370	Phase 4	Japan, Asia except Japan, North America, Europe

First Previous1Next Last